End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.92 JOD | -4.17% | -4.17% | -.--% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 20 | 19.6 | 23.4 | 21.2 | 16 | 18.4 |
Enterprise Value (EV) 1 | 25.18 | 22.1 | 25.54 | 23.03 | 20.22 | 26.92 |
P/E ratio | 32.7 x | 15.7 x | 15.2 x | -36.5 x | -6.01 x | -7.28 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.41 x | 1.36 x | 2.11 x | 1.71 x | 1.43 x | 1.62 x |
EV / Revenue | 1.77 x | 1.53 x | 2.3 x | 1.86 x | 1.81 x | 2.38 x |
EV / EBITDA | 9.84 x | 6.35 x | 7.67 x | 17.8 x | -39.1 x | 71.5 x |
EV / FCF | 13.5 x | 8.13 x | -976 x | 70 x | -25.7 x | -15.5 x |
FCF Yield | 7.39% | 12.3% | -0.1% | 1.43% | -3.89% | -6.47% |
Price to Book | 1 x | 0.94 x | 1.04 x | 0.98 x | 0.87 x | 1.28 x |
Nbr of stocks (in thousands) | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 |
Reference price 2 | 1.000 | 0.9800 | 1.170 | 1.060 | 0.8000 | 0.9200 |
Announcement Date | 3/13/19 | 6/15/20 | 4/28/21 | 3/31/22 | 3/23/23 | 3/14/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 14.22 | 14.44 | 11.08 | 12.37 | 11.16 | 11.33 |
EBITDA 1 | 2.56 | 3.48 | 3.33 | 1.296 | -0.5176 | 0.3764 |
EBIT 1 | 0.3626 | 1.452 | 1.628 | -0.7735 | -2.6 | -1.23 |
Operating Margin | 2.55% | 10.06% | 14.69% | -6.25% | -23.29% | -10.85% |
Earnings before Tax (EBT) 1 | 0.6125 | 1.356 | 1.923 | -0.5807 | -2.663 | -2.527 |
Net income 1 | 0.6125 | 1.249 | 1.542 | -0.5807 | -2.663 | -2.527 |
Net margin | 4.31% | 8.65% | 13.91% | -4.7% | -23.85% | -22.3% |
EPS 2 | 0.0306 | 0.0625 | 0.0771 | -0.0290 | -0.1331 | -0.1264 |
Free Cash Flow 1 | 1.862 | 2.72 | -0.0262 | 0.3289 | -0.7876 | -1.741 |
FCF margin | 13.09% | 18.84% | -0.24% | 2.66% | -7.05% | -15.36% |
FCF Conversion (EBITDA) | 72.74% | 78.18% | - | 25.37% | - | - |
FCF Conversion (Net income) | 303.99% | 217.77% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/13/19 | 6/15/20 | 4/28/21 | 3/31/22 | 3/23/23 | 3/14/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 5.18 | 2.5 | 2.14 | 1.83 | 4.22 | 8.52 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 2.025 x | 0.7195 x | 0.6412 x | 1.409 x | -8.157 x | 22.64 x |
Free Cash Flow 1 | 1.86 | 2.72 | -0.03 | 0.33 | -0.79 | -1.74 |
ROE (net income / shareholders' equity) | 2.97% | 6.12% | 7.14% | -2.63% | -13.3% | -15.4% |
ROA (Net income/ Total Assets) | 0.75% | 3.08% | 3.3% | -1.55% | -5.19% | -2.52% |
Assets 1 | 81.38 | 40.61 | 46.74 | 37.57 | 51.29 | 100.5 |
Book Value Per Share 2 | 1.000 | 1.040 | 1.120 | 1.080 | 0.9200 | 0.7200 |
Cash Flow per Share 2 | 0.0100 | 0.0100 | 0.0200 | 0.0200 | 0.0100 | 0.0100 |
Capex 1 | 1.11 | 2.91 | 0.8 | 0.67 | 0.83 | 0.28 |
Capex / Sales | 7.78% | 20.15% | 7.23% | 5.44% | 7.43% | 2.51% |
Announcement Date | 3/13/19 | 6/15/20 | 4/28/21 | 3/31/22 | 3/23/23 | 3/14/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 25.96M | |
-18.46% | 16.57B | |
+4.50% | 12.38B | |
+4.31% | 11.73B | |
+24.72% | 8.4B | |
-2.64% | 7.63B | |
+20.04% | 7.16B | |
+4.17% | 6.63B | |
+46.90% | 4.58B | |
-5.70% | 4.22B |
- Stock Market
- Equities
- IBNH Stock
- Financials Ibn-Alhaytham Hospital Co